| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |